CLARIVATE PLC (CLVT)
Official siteTECHNOLOGY • INFORMATION TECHNOLOGY SERVICES • NYSE
Market Cap: $1.49B
Last updated: Nov 17, 2026 at 11:04 AM ET
CLARIVATE PLC (CLVT) Earnings: Report Dates and Results
CLARIVATE (CLVT) is expected to report earnings on Feb 22, 2027. In the quarter ended Sep 30, 2026, CLARIVATE reported EPS of $0.20, above the $0.16 estimate. It beat the EPS estimate in each of the last 10 quarters.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
CLVT has an expected report date of Feb 22, 2027. Analysts' consensus for the quarter ending Dec 31, 2026 is 15.0% below the $0.20 reported for the quarter ended Dec 31, 2025.
CLVT Earnings Call
The latest CLVT earnings call transcript on file is labeled 2026Q3.
Read the 2026Q3 transcriptEarnings History
Of the 37 quarters below that had an estimate, CLVT beat 26, missed 7 and matched 4. Revenue for the quarter ended Sep 30, 2026 was $481.60M, down 9.2% from $530.30M a year earlier.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported | Revenue |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | $0.20 | $0.16 | $0.16 - $0.21 | +25.00% | Beat | +11.1% | 3 | 0 up, 2 down | Nov 3, 2026 | $481.60M |
| Jun 30, 2026 | $0.17 | $0.14 | N/A | +21.43% | Beat | -5.6% | 8 | 1 up, 6 down | Jul 29, 2026 | $587.30M |
| Mar 31, 2026 | $0.18 | $0.14 | $0.12 - $0.16 | +28.57% | Beat | +28.6% | 9 | 0 up, 1 down | Apr 29, 2026 | $585.50M |
| Dec 31, 2025 | $0.20 | $0.17 | $0.15 - $0.18 | +20.63% | Beat | -4.8% | 9 | 0 up, 1 down | Feb 24, 2026 | $617.00M |
| Sep 30, 2025 | $0.18 | $0.16 | $0.14 - $0.17 | +12.50% | Beat | -5.3% | 9 | 1 up, 1 down | Oct 29, 2025 | $530.30M |
| Jun 30, 2025 | $0.18 | $0.17 | $0.16 - $0.20 | +5.88% | Beat | -10.0% | 9 | 1 up, 0 down | Jul 30, 2025 | $621.40M |
| Mar 31, 2025 | $0.14 | $0.12 | $0.10 - $0.13 | +16.67% | Beat | 0.0% | 9 | 0 up, 1 down | Apr 29, 2025 | $593.70M |
| Dec 31, 2024 | $0.21 | $0.20 | $0.18 - $0.22 | +3.75% | Beat | -8.7% | 9 | 1 up, 6 down | Feb 19, 2025 | $663.00M |
| Sep 30, 2024 | $0.19 | $0.18 | $0.17 - $0.20 | +5.56% | Beat | -9.5% | 9 | 0 up, 1 down | Nov 6, 2024 | $622.20M |
| Jun 30, 2024 | $0.20 | $0.18 | $0.17 - $0.20 | +11.11% | Beat | -4.8% | 10 | 0 up, 1 down | Aug 6, 2024 | $650.30M |
| Mar 31, 2024 | $0.14 | $0.14 | $0.13 - $0.15 | 0.00% | In line | -22.2% | 10 | 0 up, 0 down | May 8, 2024 | $621.20M |
| Dec 31, 2023 | $0.23 | $0.21 | $0.19 - $0.23 | +9.52% | Beat | +4.5% | 11 | 0 up, 0 down | Feb 27, 2024 | $683.70M |
| Sep 30, 2023 | $0.21 | $0.18 | $0.16 - $0.20 | +16.67% | Beat | +5.0% | 11 | 2 up, 0 down | Nov 7, 2023 | $647.20M |
| Jun 30, 2023 | $0.21 | $0.20 | $0.17 - $0.24 | +5.00% | Beat | -4.5% | 11 | 1 up, 0 down | Aug 3, 2023 | $668.80M |
| Mar 31, 2023 | $0.18 | $0.15 | $0.13 - $0.17 | +20.00% | Beat | -14.3% | 9 | 0 up, 0 down | May 9, 2023 | $629.10M |
| Dec 31, 2022 | $0.22 | $0.17 | $0.12 - $0.20 | +29.41% | Beat | -4.3% | 8 | 0 up, 0 down | Mar 1, 2023 | $675.30M |
| Sep 30, 2022 | $0.20 | $0.17 | $0.16 - $0.21 | +17.65% | Beat | +25.0% | 8 | 0 up, 0 down | Nov 8, 2022 | $635.70M |
| Jun 30, 2022 | $0.22 | $0.20 | $0.19 - $0.23 | +10.00% | Beat | +29.4% | 9 | 0 up, 0 down | Aug 9, 2022 | $686.60M |
| Mar 31, 2022 | $0.21 | $0.18 | $0.15 - $0.21 | +16.67% | Beat | +50.0% | 8 | 0 up, 0 down | May 9, 2022 | $662.20M |
| Dec 31, 2021 | $0.23 | $0.21 | $0.17 - $0.24 | +9.52% | Beat | +4.5% | 9 | N/A | Mar 10, 2022 | $560.70M |
| Sep 30, 2021 | $0.16 | $0.16 | $0.12 - $0.19 | 0.00% | In line | +14.3% | 8 | N/A | Oct 28, 2021 | $442.10M |
| Jun 30, 2021 | $0.17 | $0.17 | $0.15 - $0.18 | 0.00% | In line | -5.6% | 6 | N/A | Jul 29, 2021 | $445.70M |
| Mar 31, 2021 | $0.14 | $0.12 | $0.11 - $0.18 | +16.67% | Beat | +100.0% | 6 | N/A | May 10, 2021 | $428.40M |
| Dec 31, 2020 | $0.22 | $0.17 | $0.14 - $0.18 | +29.41% | Beat | +69.2% | 5 | N/A | Feb 25, 2021 | $455.65M |
| Sep 30, 2020 | $0.14 | $0.15 | $0.13 - $0.16 | -6.67% | Miss | 0.0% | 7 | N/A | Oct 29, 2020 | $284.36M |
| Jun 30, 2020 | $0.18 | $0.14 | $0.13 - $0.16 | +28.57% | Beat | N/A | 6 | N/A | Jul 30, 2020 | $273.50M |
| Mar 31, 2020 | $0.07 | $0.09 | $0.07 - $0.13 | -22.22% | Miss | N/A | 5 | N/A | May 4, 2020 | $240.59M |
| Dec 31, 2019 | $0.13 | $0.16 | $0.12 - $0.19 | -18.75% | Miss | N/A | 4 | N/A | Feb 27, 2020 | $255.01M |
| Sep 30, 2019 | $0.14 | $0.06 | $0.01 - $0.15 | +133.33% | Beat | N/A | 2 | N/A | Nov 5, 2019 | $243.00M |
| Jun 30, 2019 | -$0.04 | -$0.18 | -$0.18 - $0.15 | +77.78% | Beat | N/A | 3 | N/A | Aug 7, 2019 | $242.31M |
| Mar 31, 2019 | -$9.69 | $0.12 | N/A | N/A | N/A | N/A | N/A | N/A | Apr 26, 2019 | $234.03M |
| Dec 31, 2018 | -$0.09 | $0.16 | N/A | -156.25% | Miss | -160.0% | N/A | N/A | Feb 27, 2019 | $245.25M |
| Sep 30, 2018 | -$0.01 | $0.19 | N/A | -105.26% | Miss | -105.9% | N/A | N/A | Nov 5, 2018 | $242.90M |
| Jun 30, 2018 | Not reported | $0.15 | N/A | N/A | Not reported | N/A | N/A | N/A | Aug 3, 2018 | $243.30M |
| Mar 31, 2018 | Not reported | $0.14 | N/A | N/A | Not reported | N/A | N/A | N/A | Jun 29, 2018 | $237.03M |
| Dec 31, 2017 | $0.15 | $0.15 | $0.14 - $0.16 | 0.00% | In line | -6.3% | 2 | N/A | Mar 30, 2018 | $619.81M |
| Sep 30, 2017 | $0.17 | $0.16 | $0.16 - $0.17 | +6.25% | Beat | +30.8% | 4 | N/A | Nov 6, 2017 | N/A |
| Jun 30, 2017 | $0.14 | $0.19 | N/A | -26.32% | Miss | -6.7% | 5 | N/A | Aug 4, 2017 | N/A |
| Mar 31, 2017 | $0.02 | $0.16 | N/A | -87.50% | Miss | -81.8% | N/A | N/A | May 9, 2017 | N/A |
| Dec 31, 2016 | $0.16 | $0.15 | N/A | +6.67% | Beat | +6.7% | N/A | N/A | Feb 24, 2017 | $514.25M |
Annual EPS
EPS for the fiscal year ended Dec 31, 2025 was $0.70, within 4 cents of the year before. It was $0.55 for the year ended Dec 31, 2016, the oldest of the 10 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Dec 31, 2025 | $0.70 | N/A |
| Dec 31, 2024 | $0.74 | -10.8% |
| Dec 31, 2023 | $0.83 | N/A |
| Dec 31, 2022 | $0.85 | +21.4% |
| Dec 31, 2021 | $0.70 | +14.8% |
| Dec 31, 2020 | $0.61 | N/A |
| Dec 31, 2019 | -$9.46 | N/A |
| Dec 31, 2018 | -$0.10 | -120.8% |
| Dec 31, 2017 | $0.48 | -12.7% |
| Dec 31, 2016 | $0.55 | N/A |
Earnings Calls
The 8 most recent earnings calls are listed below; the latest, 2026Q3 for the period ended Sep 30, 2026, runs about 4,200 words across 7 speakers.
| Call | Period ending | Words | Speakers | Transcript |
|---|---|---|---|---|
| 2026Q3 | Sep 30, 2026 | 4,222 | 7 | |
| 2026Q2 | Jun 30, 2026 | 5,078 | 9 | |
| 2026Q1 | Mar 31, 2026 | 5,897 | 11 | |
| 2025Q4 | Dec 31, 2025 | 6,080 | 11 | |
| 2025Q3 | Sep 30, 2025 | 5,984 | 10 | |
| 2025Q2 | Jun 30, 2025 | 3,486 | 10 | |
| 2025Q1 | Mar 31, 2025 | 4,948 | 10 | |
| 2024Q4 | Dec 31, 2024 | 6,301 | 12 |
2026Q3 Earnings Call
Opening remarks
Mark Donohue Vice President, Investor Relations Thank you, and good morning, everyone. Thank you for joining us for the Clarivate Third Quarter 2026 Earnings Conference Call. As a reminder, this conference call is being recorded and webcast and is copyrighted property of Clarivate. Any rebroadcast of this information in whole or in part without prior written consent of Clarivate is prohibited. The accompanying earnings call presentation is available on the Investor Relations section of the company's website. During our call, we may make certain forward-looking statements within the meaning of applicable securities laws. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the business or developments in Clarivate's business to differ materially from the anticipated results, performance, achievements or developments expressed or implied by such forward-looking statements. Information about the factors that could cause actual results to differ materially from anticipated results or performance can be found in Clarivate's filings with the SEC and on the company's website. Our discussion will include non-GAAP measures or adjusted numbers. Clarivate believes non-GAAP results are useful in order to enhance the understanding of our ongoing operating performance, but they are a supplement to and should not be considered in isolation from or as a substitute for GAAP financial measures. Reconciliations of these measures to GAAP measures are available in our earnings release and supplemental presentation on our website. With me today are Matti Shem Tov, Chief Executive Officer; and Michael Easton, Chief Financial Officer. After our prepared remarks, we'll open up the call to your questions. And with that, it's a pleasure to turn the call over to Matti.
Matti Shem Tov CEO Thank you, Mark, and thank you, everyone, for joining us. The third quarter marks a major milestone in Clarivate's continued transformation. We completed the strategic sale of the Life Sciences & Healthcare segment ahead of schedule. This positions Clarivate as a more focused, higher-quality recurring business, centered on 2 scaled market-leading segments, Academia & Government and IP. Both segments are driving commercial traction and customer validation from our AI-led innovation. Web of Science Research Intelligence and IPOne are strong examples of that innovation in practice. I will discuss this in more detail later. In Q2, we said that we had the building blocks in place to accelerate organic growth. The progress we made this quarter is proof that we delivered on our commitments. Today's message is straightforward. We have a clear path to accelerating sustained organic growth, expanding free cash flow and reducing leverage, all of which will continue to create long-term value for shareholders.
Frequently Asked Questions About CLVT
When is CLARIVATE's next earnings date?
CLARIVATE's next earnings report is expected for Feb 22, 2027.
Did CLVT beat earnings estimates last quarter?
Yes. CLARIVATE reported EPS of $0.20 for the quarter ended Sep 30, 2026, above the $0.16 estimate, a 25.00% surprise.
What EPS do analysts expect from CLVT next quarter?
The consensus EPS estimate for CLARIVATE for the quarter ending Dec 31, 2026 is $0.17 from 10 analysts, with estimates from $0.13 to $0.22.
How often does CLVT beat earnings estimates?
CLARIVATE beat the EPS estimate in each of the last 10 quarters, with an average surprise of +15.11%.
CLVT pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors, Government Contracts